The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Pills on a table
Monday 7 November 2016
Scotland has today made an announcement that puts the nation’s healthcare system ahead of the other UK nations when it comes to ovarian cancer diagnosis, access to drugs and guidelines to treatment. The Scottish Medicines Consortium (SMC) today greenlit new drug olaparib (Lynparza®) for use in the...
Yiyan in the lab
Monday 19 September 2016
Dr Yiyan Zheng (pictured) is a post-doctoral researcher in Professor Ahmed Ashour Ahmed’s lab at the Weatherall Institute of Molecular Medicine (IMM), University of Oxford. Target Ovarian Cancer has funded Dr Zheng’s work since 2013. We visited the lab to ask him about his important work on ovarian...
Cancer Drugs Fund
Friday 29 July 2016
Today sees a new Cancer Drugs Fund (CDF) swing into action, with a new set of rules and implications for people with a diagnosis of cancer across England. The CDF currently funds bevacizumab (Avastin) for first line treatment of ovarian cancer, which offers up to nine months’ overall survival in...
Thursday 25 February 2016
Today, NHS England’s thoughts turn to the future of the Cancer Drugs Fund (CDF) as it makes a landmark decision following a consultation on next steps for the Fund. Target Ovarian Cancer Chief Executive Annwen Jones has been one of three lay representatives on the Cancer Drugs Fund Panel since 2014...